Latest News

Dr Roy Beveridge on Physician Reaction to Value-Based Payment Models
The introduction of value-based payment models means that the goals of providing optimal patient care have become aligned for the clinician and the insurer, leading to more cooperation and support, said Roy Beveridge, MD, chief medical officer of Humana. This represents a shift from the more adversarial relationship between physicians and payers that existed under fee-for-service models.
The trial successfully improved progression-free survival and also tested a BRCA diagnostic test in patients with ovarian cancer.
As CMS moves forward with the Medicare Access and CHIP Reauthorization Act, it is funding organizations to help solo and small practices succeed under the new payment system.
Dr Carrie Stricker on How Carevive Integrates Patient-Reported Outcomes Into Care Planning
Carevive recognizes the importance of including patient-reported outcomes into the care planning process, so they have developed surveys that will provide patients with the resources to address those concerns, according to Carrie Stricker, PhD, RN, AOCN, chief clinical officer and co-founder of Carevive.
Weill Cornell Medicine and Boehringer Ingelheim have announced a collaboration that will investigate novel approaches to treating chronic respiratory disease.
Podcast: This Week in Managed Care—HHS Proposes New ACA Rule, and Other News
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Dr Thomas C. Quinn Discusses Global Trends in HIV Transmission
The spread of HIV has stabilized in some areas of the world, but continues to rise in others, said Thomas C. Quinn, MD, director of the Johns Hopkins Center for Global Health.
A study in Diabetes Care examined the effects of high-deductible health plans on healthcare utilization for diabetes patients with varying incomes.
The policy brief outlines House GOP thinking on a universal, refundable, and portable tax credit, state-based high-risk pools, and how to repeal Medicaid expansion. But many specifics, including what it would cost a typical family, are unclear.
A look at Seema Verma’s approach to reforming healthcare policy, and what it could mean for Medicare and Medicaid if she is confirmed as CMS administrator.
An e-mail, from Mark Merritt, president and CEO of the trade group Pharmaceutical Care Management Association, to the organization’s board, lays out a plan to develop an aggressive campaign to convince the new administration that the fault rests with pharmaceutical manufacturers.
This Week in Managed Care: February 17, 2017
This week, the top managed care stories included the end of 2 insurance megamergers, a proposed rule to tighten restrictions for the Affordable Care Act, and new legislation in New Jersey provides the nation's strictest mandates for treating addiction.

From the Journals

The shift to value-based care, concurrent with innovations in immune-based care, will create challenges in oncology. What should be the physician and manufacturer responsibility during these changing times?
Patients, caregivers, and providers need education on immunotherapy treatment, support in patient-provider communications as well as support in mitigating the financial impact of immunotherapy treatment.
An oncologist provides insight on his experience with using CAR-T therapy in the clinic and his prediction for the future of this revolutionary treatment.
A health plan–sponsored care management program that included a coaching for activation intervention was associated with reduced emergency department visits and hospital admissions, and better clinical outcomes.
A retrospective claims analysis showed that synchronized refill schedules were associated with better medication adherence among Medicare Advantage patients taking multiple maintenance medications.
Hepatitis C virus treatment is often restricted in Medicaid patients. This analysis evaluates the clinical and cost impacts of treating all Medicaid patients versus the current status quo.
Finding ways to improve outcomes and reduce the cost of care is imperative for patients with chronic conditions. A combination of health information technology use, patient and provider engagement, and attention to the clinical services can promote success in this area.
Immunotherapy treatments are not without side effects. What do patients and their families need to know so they are more aware?
Community oncologists will be at the forefront of using immunotherapies and will need to be strong advocates for greater information and affordability of therapies.
Compendia
COPD Compendium
Diabetes Compendium
GI Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Know Your News
HF Compendium
Formulary
Upcoming Partner Events
March 1-2, 2017
Scottsdale, AZ
March 9-10, 2017
Washington, DC
March 15-16, 2017
Philadelphia, PA
March 16-17, 2017
Baltimore, MD
April 19-20, 2017
San Francisco, CA
August 16-17, 2017
Philadelphia, PA
October 24-25, 2017
San Francisco, CA
Managed Care Cast
Managed Care Cast

Most Popular

AJMC Strategic Alliance

$vacMongoViewPlus$